Revance Therapeutics Inc. (RVNC) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-08
5:07 pm
Purchase
2021-12-3113GRevance Therapeutics, Inc.
RVNC
GIC Private Limited4,176,080
5.820%
345,129increase
(+9.01%)
Filing
History
2022-02-04
09:29 am
Sale
2021-12-3113GRevance Therapeutics, Inc.
RVNC
Wellington Management Group LLP1,104,531
1.540%
-2,293,341decrease
(-67.49%)
Filing
History
2022-02-03
4:41 pm
Purchase
2021-12-3113GRevance Therapeutics, Inc.
RVNC
BlackRock Inc.
BLK
5,334,099
7.400%
321,747increase
(+6.42%)
Filing
History
2022-01-18
12:59 pm
Purchase
2021-12-3113GRevance Therapeutics, Inc.
RVNC
JPMORGAN CHASE & CO
JPM
6,794,223
9.400%
2,727,181increase
(+67.06%)
Filing
History
2021-02-16
1:29 pm
Sale
2020-12-3113GRevance Therapeutics, Inc.
RVNC
ArrowMark Colorado Holdings, LLC2,964,135
4.500%
-1,876,501decrease
(-38.77%)
Filing
History
Goto Prev, 0, 1, 2